18 and older, any sex, with Inclusion, Social. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Attitudes Measured With the ATTID-QuestionnairePrimary· Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)
The ATTID-SF Questionnaire encompassing three core components. The affective component refers to emotional responses toward individuals with intellectual disabilities. The cognitive component encompasses beliefs, knowledge, and perceptions about this population. The behavioral component reflects self-reported actions. The short form comprises 35 items rated on a 5-point Likert scale (1 = strongly agree to 5 = strongly disagree), with higher scores indicating more negative attitudes. Items are grouped into five factors: (1) interaction, (2) sensitivity/tenderness, (3) discomfort, (4) knowledge
T1 Discomfort
Group
Value
95% CI
Participants Living in Host Towns
1.95
± 0.77
Participants Not Living in Host Towns
2.20
± 0.76
T1 Knowledge of capacity and rights
Group
Value
95% CI
Participants Living in Host Towns
1.78
± 0.55
Participants Not Living in Host Towns
2.04
± 0.55
T1 Interaction
Group
Value
95% CI
Participants Living in Host Towns
2.22
± 0.65
Participants Not Living in Host Towns
2.41
± 0.71
T1 Sensitivity or tenderness
Group
Value
95% CI
Participants Living in Host Towns
2.57
± 0.95
Participants Not Living in Host Towns
2.71
± 0.94
T1 Knowledge of causes
Group
Value
95% CI
Participants Living in Host Towns
1.89
± 0.55
Participants Not Living in Host Towns
2.07
± 0.42
T2 Discomfort
Group
Value
95% CI
Participants Living in Host Towns
1.92
± 0.81
Participants Not Living in Host Towns
2.19
± 0.76
T2 Knowledge of capacity and rights
Group
Value
95% CI
Participants Living in Host Towns
1.82
± 0.51
Participants Not Living in Host Towns
1.99
± 0.50
T2 Interaction
Group
Value
95% CI
Participants Living in Host Towns
2.21
± 0.63
Participants Not Living in Host Towns
2.45
± 0.64
Sponsor's own description
This research aims to evaluate the impact of the project "170 Nations - 170 Inclusive Communities" of the Special Olympics World Games 2023 (SOWG 23) on sustain inclusive structures for people with intellectual disabilities (ID). The research utilizes a quasi-experimental research design and a qualitative research design and will synthesize qualitative and quantitative data to display successful and non-successful interventions for more inclusive communities. The research will target 56 host communities of SOWG 23 and 56 non-host communities, interviewing 200 people with ID and a minimum of 400 key stakeholders, as well as conducting qualitative interviews and focus groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by German University of Health and Sports
Last refreshed: 28 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05871450.